Gender difference in miRNA-mediated T cell aging during viral infection
病毒感染期间 miRNA 介导的 T 细胞衰老的性别差异
基本信息
- 批准号:9896225
- 负责人:
- 金额:$ 9.62万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-06-17 至 2020-11-30
- 项目状态:已结题
- 来源:
- 关键词:Acute Hepatitis CAffectAfrican AmericanAgeAgingBiological AssayCD28 geneCD3 AntigensCD4 Positive T LymphocytesCD8-Positive T-LymphocytesCell AgingCell physiologyCellsCharacteristicsChronic Hepatitis CDiseaseExhibitsFc ReceptorFemaleFunctional disorderGenderGenesGenotypeGoalsHepatitis CHepatitis C virusHumanImmune responseImmunityImpairmentIndividualInfectionKiller CellsLectinMediatingMicroRNAsModelingNatural HistoryOutcomePatientsPhosphoric Monoester HydrolasesPlayRaceReceptor ActivationReceptor SignalingRegulationRoleSignal TransductionT cell regulationT cell responseT-Cell ReceptorT-LymphocyteTestingTimeTranslatingTranslationsUp-RegulationVariantViralViral AntigensViral Load resultVirusVirus Diseasesbasecaucasian Americanchronic infectiongender differenceimmunological statusimprovedloss of functionmalememberprematureracial differencereceptorresponsetranslational approach
项目摘要
Major racial and gender differences have been recognized in the natural history of hepatitis C virus (HCV)
infection; however, the underlying mechanism for this phenomenon remain poorly understood. In studying the
natural history of HCV infection, it has been well-recognized that i) white females have an 8-fold greater chance
of spontaneous viral clearance of acute HCV infection; ii) African American (AA) males with genotype 1 HCV
infection have higher rates of viral persistence or chronic infection than Caucasian Americans (CA); and iii) these
differences are not explained by the baseline viral loads, genotypes, or disease characteristics, but related to
the host immune status, in particular T cell responses. In studying the effect of viral infection on T cell functions,
we and others have recently found that chronic HCV infection leads to T cell dysfunction mediated through up-
regulation of aging markers, including killer cell lectin-like receptor subfamily G member 1 (KLRG1) and dual
specific phosphatase 6 (DUSP6), concomitant with a decline of microRNA-181a (miR181) levels in CD4 T cells.
These observations suggest that the inability of host to clear virus during chronic infection may be a result of
microRNA-mediated impairment of host immunity, and that race/gender influences on the natural history of HCV
infection may be due to a difference in virus-induced, miRNA-mediated signaling. Indeed, with increasing age,
KLRG1 is up-regulated and leads to inhibition of T cell receptor (TCR) signaling, whereas DUSP6 is increased
and leads to recalibration of the TCR activation threshold; miR181 declines to permit translation of a set of genes
related to T cell inhibition. However, the mechanisms underlying miR181/KLRG1/DUSP6 expression and
regulation of premature T cell aging during HCV infection and their relationships to the gender difference in the
natural history of HCV infection remain unclear. We thus hypothesize that virus-induced microRNAs may
exhibit a gender difference, which may affect T cell responses that contribute to the natural history of
HCV infection. To test this hypothesis, we will carry out the following specific aims: 1) Does HCV induce a
different level of miR181, resulting in different T cell responses from male and female HCV-infected or HCV-
resolved patients? 2) Are there any differences in miR181 expression in CD4 and CD8 T cells from male and
female healthy subjects in response to stimulation by TCR antibodies (anti-CD3/CD28) or HCV antigens? 3)
What is the role of HCV-mediated miR181 on host immune responses by gain- or loss-of-function assays,
including virus-specific T cell responses? The overall goal of this supplemental proposal is to employ a
translational approach to obtain a unified overview on whether HCV may induce different levels of miR181 in T
cells from male and female subjects, which may translate into different levels of host T cell responses, and thus
contribute to different outcomes of HCV infection.
在丙型肝炎病毒(HCV)的自然史上已经确认了主要的种族和性别差异
感染;但是,这种现象的基本机制仍然很少理解。在研究
HCV感染的自然历史,已经被众所周知,我的白人女性的机会更大8倍
急性HCV感染的自发病毒清除率; ii)具有基因型1 HCV的非裔美国人(AA)男性
感染的病毒持久性或慢性感染率高于高加索人(CA); iii)这些
基线病毒负荷,基因型或疾病特征没有解释差异,而是与
宿主免疫状态,特别是T细胞反应。在研究病毒感染对T细胞功能的影响时,
我们和其他人最近发现,慢性HCV感染会导致T细胞功能障碍通过UP-介导
衰老标记物的调节,包括杀伤细胞凝集素样受体亚家族G成员1(KLRG1)和双重
特异性磷酸酶6(DUSP6),与CD4 T细胞中microRNA-181a(miR181)水平的下降。
这些观察结果表明,宿主无法在慢性感染期间清除病毒
microRNA介导的宿主免疫损害,种族/性别对HCV的自然历史的影响
感染可能是由于病毒诱导的miRNA介导的信号传导差异所致。确实,随着年龄的增长,
KLRG1被上调,导致T细胞受体(TCR)信号传导抑制,而DUSP6增加
并导致TCR激活阈值重新校准; miR181拒绝允许翻译一组基因
与T细胞抑制有关。但是,mir181/klrg1/dusp6表达和
调节HCV感染期间过早T细胞衰老及其与性别差异的关系
HCV感染的自然病史尚不清楚。因此,我们假设病毒诱导的microRNA可能
表现出性别差异,可能会影响T细胞反应,从而有助于自然历史
HCV感染。为了检验这一假设,我们将执行以下特定目的:1)HCV是否诱导A
不同水平的miR181,导致与男性和女性HCV感染或HCV-的T细胞反应不同
解决的患者? 2)MIR181表达在CD4和CD8 T细胞中是否存在任何差异
女性健康受试者响应TCR抗体(抗CD3/CD28)还是HCV抗原刺激? 3)
HCV介导的miR181在通过获得或功能丧失测定的宿主免疫反应中的作用是什么,
包括病毒特异性T细胞反应?该补充提议的总体目标是采用
转化方法获得统一的概述,以了解HCV是否可能在t中诱导不同水平的miR181
来自男性和女性受试者的细胞,这些细胞可能转化为不同水平的宿主T细胞反应,因此
有助于HCV感染的不同结果。
项目成果
期刊论文数量(16)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Long Non-coding RNA GAS5 Regulates T Cell Functions via miR21-Mediated Signaling in People Living With HIV.
- DOI:10.3389/fimmu.2021.601298
- 发表时间:2021
- 期刊:
- 影响因子:7.3
- 作者:Nguyen LNT;Nguyen LN;Zhao J;Schank M;Dang X;Cao D;Khanal S;Chand Thakuri BK;Lu Z;Zhang J;Li Z;Morrison ZD;Wu XY;El Gazzar M;Ning S;Wang L;Moorman JP;Yao ZQ
- 通讯作者:Yao ZQ
A Matter of Life or Death: Productively Infected and Bystander CD4 T Cells in Early HIV Infection.
- DOI:10.3389/fimmu.2020.626431
- 发表时间:2020
- 期刊:
- 影响因子:7.3
- 作者:Cao D;Khanal S;Wang L;Li Z;Zhao J;Nguyen LN;Nguyen LNT;Dang X;Schank M;Thakuri BKC;Zhang J;Lu Z;Wu XY;Morrison ZD;El Gazzar M;Ning S;Moorman JP;Yao ZQ
- 通讯作者:Yao ZQ
Immune Activation Induces Telomeric DNA Damage and Promotes Short-Lived Effector T Cell Differentiation in Chronic HCV Infection.
- DOI:10.1002/hep.32008
- 发表时间:2021-11
- 期刊:
- 影响因子:0
- 作者:Nguyen LN;Nguyen LNT;Zhao J;Schank M;Dang X;Cao D;Khanal S;Thakuri BKC;Zhang J;Lu Z;Wu XY;El Gazzar M;Ning S;Wang L;Moorman JP;Yao ZQ
- 通讯作者:Yao ZQ
HIV-1 Latency and Viral Reservoirs: Existing Reversal Approaches and Potential Technologies, Targets, and Pathways Involved in HIV Latency Studies.
- DOI:10.3390/cells10020475
- 发表时间:2021-02-23
- 期刊:
- 影响因子:6
- 作者:Khanal S;Schank M;El Gazzar M;Moorman JP;Yao ZQ
- 通讯作者:Yao ZQ
LncRNA HOTAIRM1 promotes MDSC expansion and suppressive functions through the HOXA1-miR124 axis during HCV infection.
- DOI:10.1038/s41598-020-78786-1
- 发表时间:2020-12-16
- 期刊:
- 影响因子:4.6
- 作者:Thakuri BKC;Zhang J;Zhao J;Nguyen LN;Nguyen LNT;Khanal S;Cao D;Dang X;Schank M;Wu XY;Morrison ZD;Gazzar ME;Li Z;Jiang Y;Ning S;Wang L;Moorman JP;Yao ZQ
- 通讯作者:Yao ZQ
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Zhi Q. Yao其他文献
Zhi Q. Yao的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Zhi Q. Yao', 18)}}的其他基金
Dual specific gene editing drugs delivered by nanoparticles targeting HBV/HIV coinfection
针对 HBV/HIV 双重感染的纳米颗粒递送的双特异性基因编辑药物
- 批准号:
10403587 - 财政年份:2021
- 资助金额:
$ 9.62万 - 项目类别:
HIV infection-induced mitochondrial dysfunction and premature T cell aging
HIV感染引起的线粒体功能障碍和T细胞过早衰老
- 批准号:
10203459 - 财政年份:2021
- 资助金额:
$ 9.62万 - 项目类别:
Mitochondrial Dysfunction in Aging CD4 T cells in HIV-immune Non-responders.
HIV 免疫无反应者中衰老 CD4 T 细胞的线粒体功能障碍。
- 批准号:
10845843 - 财政年份:2021
- 资助金额:
$ 9.62万 - 项目类别:
Dual specific gene editing drugs delivered by nanoparticles targeting HBV/HIV coinfection
针对 HBV/HIV 双重感染的纳米颗粒递送的双特异性基因编辑药物
- 批准号:
10161447 - 财政年份:2021
- 资助金额:
$ 9.62万 - 项目类别:
Telomere loss and T cell aging in HBV vaccine response in HCV-infected individual
HCV 感染者的 HBV 疫苗反应中的端粒丢失和 T 细胞老化
- 批准号:
10265317 - 财政年份:2019
- 资助金额:
$ 9.62万 - 项目类别:
Telomere loss and T cell aging in HBV vaccine response in HCV-infected individual
HCV 感染者的 HBV 疫苗反应中的端粒丢失和 T 细胞老化
- 批准号:
10455526 - 财政年份:2019
- 资助金额:
$ 9.62万 - 项目类别:
Premature T cell aging and vaccine failure in chronic viral infection
慢性病毒感染中 T 细胞过早衰老和疫苗失败
- 批准号:
9023117 - 财政年份:2016
- 资助金额:
$ 9.62万 - 项目类别:
ShEEP Proposal for a Multiuser Advanced Biosafe Flow Cytometer
ShEEP 针对多用户高级生物安全流式细胞仪的提案
- 批准号:
9211532 - 财政年份:2016
- 资助金额:
$ 9.62万 - 项目类别:
Telomere attrition and T cell aging in vaccine failure during HIV infection
HIV 感染期间疫苗失败时的端粒磨损和 T 细胞老化
- 批准号:
10581156 - 财政年份:2016
- 资助金额:
$ 9.62万 - 项目类别:
相似国自然基金
TiC-TiB2颗粒喷射成形原位合成及其对M2高速工具钢共晶碳化物形成与演化的影响
- 批准号:52361020
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
植被群落演替对河道水流结构和纵向离散特性影响机制研究
- 批准号:52309088
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
热带印度洋海表皮温日变化的数值模拟及对海气热通量的影响
- 批准号:42376002
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
SGO2/MAD2互作调控肝祖细胞的细胞周期再进入影响急性肝衰竭肝再生的机制研究
- 批准号:82300697
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
协同遥感和气候模型的城市高温热浪时空特征及其对热暴露影响研究
- 批准号:42371397
- 批准年份:2023
- 资助金额:46 万元
- 项目类别:面上项目
相似海外基金
A smartphone-enabled point of care HCV Ag diagnostics to reduce HCV-related health disparities
支持智能手机的 HCV Ag 护理点诊断,可减少与 HCV 相关的健康差异
- 批准号:
10570705 - 财政年份:2022
- 资助金额:
$ 9.62万 - 项目类别:
A smartphone-enabled point of care HCV Ag diagnostics to reduce HCV-related health disparities
支持智能手机的 HCV Ag 护理点诊断,可减少与 HCV 相关的健康差异
- 批准号:
10701906 - 财政年份:2022
- 资助金额:
$ 9.62万 - 项目类别:
COVID-19 and the MWCCS: Pathophysiology, Impact and Outcomes
COVID-19 和 MWCCS:病理生理学、影响和结果
- 批准号:
10223572 - 财政年份:2019
- 资助金额:
$ 9.62万 - 项目类别: